BRODERICK EATON: Open Payments
NPI 1992115646 · WYNNE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$10,319 in 27 payments from 8 companies in 2025. Trend: 2023 $4,253 · 2024 $9,624 · 2025 $10,319
Speaker / faculty: $9,450Travel & lodging: $476Food & beverage: $393
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 18 | $10,119 |
| PFIZER INC. | 3 | $75 |
| Braeburn Inc. | 1 | $33 |
| Averitas Pharma Inc. | 1 | $28 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
| SANOFI-AVENTIS U.S. LLC | 1 | $16 |
| Merck Sharp & Dohme LLC | 1 | $16 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
Products named: OTEZLA, REPATHA, PREVNAR 20, BRIXADI, QUTENZA, TRUMENBA, CAPLYTA, TZIELD.
Industry payments across AR — which companies pay providers there.
